Coagulation analyzer market seen growing to $4.95B by 2030

The Business Research Company projects the coagulation analyzer market will rise from $3.26 billion in 2025 to $4.95 billion by 2030, driven by cardiovascular disease, faster diagnostics and more automated testing. North America led the market in 2025, while Asia-Pacific is expected to grow the fastest.

Why it matters: - Coagulation analyzers help clinicians assess blood clotting, guide anticoagulant treatment and detect bleeding disorders such as hemophilia. - Demand is rising as cardiovascular disease becomes more common and healthcare systems rely more on faster, more automated diagnostics. - The market’s growth reflects broader pressure to improve patient safety monitoring and reduce turnaround time in testing.

What happened: - The Business Research Company released a coagulation analyzer market report on July 31, 2026. - The report says the market will grow from $3.26 billion in 2025 to $3.53 billion in 2026. - The report projects the market will reach $4.95 billion by 2030. - The forecast implies an 8.2% CAGR from 2025 to 2026 and an 8.8% CAGR through 2030. - The report includes market outlooks for Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download a free sample of the report. - View the full coagulation analyzer market report.

The details: - The report links past growth to rising cardiovascular disease, broader anticoagulant therapy monitoring, improved hospital diagnostic facilities, standardized coagulation testing methods and more surgical procedures. - The forecast points to demand for rapid coagulation diagnostics, wider decentralized testing and more investment in advanced hematology analyzers. - The report also highlights patient safety monitoring, intelligent diagnostic platforms, fully automated coagulation systems, high-sensitivity clotting assays, AI-driven result interpretation and point-of-care testing. - Coagulation analyzers are used to measure platelet levels and assess how well blood clots. - The devices are used to monitor patients taking anticoagulants such as aspirin, heparin and warfarin. - The report says North America was the largest market in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region during the forecast period.

Between the lines: - The growth outlook suggests coagulation testing is moving from a routine lab function toward a more automated and distributed diagnostic workflow. - The emphasis on AI, decentralization and point-of-care testing points to a market that is being shaped by speed, workflow efficiency and earlier clinical intervention. - The included regional split shows the market is already mature in North America but still expanding quickly in emerging healthcare systems across Asia-Pacific.

What's next: - The market’s next phase will likely center on automation, workflow integration and faster interpretation of clotting results. - Adoption should continue to track cardiovascular disease rates, surgical volumes and broader use of anticoagulant monitoring. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated visuals. - More information is available through the company’s report sample and full report links above.

The bottom line: - Coagulation analyzers are moving into a growth cycle powered by clinical demand, automation and faster diagnostics, with North America leading today and Asia-Pacific set to outpace other regions.